Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

¿Qué es la condromalacia? Síntomas y tratamiento

¿Qué es la condromalacia? La condromalacia,…

Assumptions of how antibiotics work may be incorrect

Bacterial infections are the No. 1 cause of…

Ontario scientist thinks old drugs could become our new antibiotics

As the world loses its upper hand in the…

ESTRÉS OXIDATIVO Y OSTEOARTRITIS – SYNOLIS VA

INTRODUCCIÓN El estrés oxidativo y las ROS…

WHO’s ‘priority pathogens’ list highlights urgent need for new drugs

The World Health Organization has released its…

WEBINAR “La evaluación y el manejo de la infección espinal” – Dr. Christopher Kleck

Únase a nosotros mientras presentamos al Dr….

Hospital floors a greater source of infection than previously thought

The floors of patient rooms in hospitals are…

31% de atletas de élite desarrollará artrosis

Durante años se consideró que la artrosis era…

Hospital acquired drug resistant infections, deaths rose 15% from 2019-20: CDC

Hospital-acquired drug-resistant infections,…

Current Use of Bone Substitutes in Maxillofacial Surgery

sulfato-de-calcio-en-cirugia-p…